查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508659

病患自控镇痛帮浦市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Patient-controlled Analgesic Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于病患自控镇痛帮浦市场的综合报告。该报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

关键见解

  • 病患自控镇痛帮浦市场规模（2024 年）：3.854 亿美元
  • 预计市场价值（2033 年）：7.12 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：7.1%

病人自控式止痛帮浦市场 - 研究范围

患者自控镇痛帮浦可让患者在安全剂量范围内自行给药，在有效控制疼痛方面发挥重要作用。这些帮浦用于医院、门诊和家庭护理环境，以满足患者在各种医疗条件下的不同需求，包括术后疼痛管理、慢性疼痛和安宁疗护。

推动市场成长的因素：

患者自控镇痛泵的全球市场是由几个关键因素推动的，包括慢性疼痛疾病的流行、外科手术的增加以及对个性化疼痛管理解决方案的日益偏好。技术进步也促进了市场成长，例如更安全、更易于使用的智慧泵市场的发展。此外，控制医疗成本的努力以及由于患者便利而转向门诊和家庭护理的举措进一步刺激了市场扩张。

市场限制因素：

儘管预计会有良好的成长，但患者自控镇痛泵市场面临着严格的监管要求、对用药错误的担忧以及先进泵技术的高成本等课题。在某些地区，这些设备的报销范围有限也对市场渗透构成障碍，特别是在新兴经济体。

市场机会：

由于给药技术的进步、医疗保健支出的增加以及全球老年人口的扩大，患者自控镇痛泵市场提供了巨大的成长机会。远端监控和数据分析等数位健康解决方案的整合将改善患者治疗结果和营运效率，推动市场成长。策略联盟、合作伙伴关係以及研发投资对于在不断变化的市场格局中利用新机会和保持竞争优势至关重要。

本报告解决的关键问题

  • 推动病患自控镇痛帮浦市场成长的关键因素是什么？
  • 哪些类型的帮浦和应用正在推动其在各种医疗保健环境中的采用？
  • 技术进步如何改变病人自控式镇痛帮浦市场的竞争格局？
  • 谁是对市场做出贡献的主要参与者？ 他们采取了哪些策略来维持市场影响力？
  • 全球病人自控镇痛帮浦市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场背景

  • 市场动态
  • 情势预测
  • 机会地图分析
  • 产品生命週期分析
  • 供应链分析
  • 投资可行性矩阵
  • 价值链分析
  • PESTLE和波特五力分析
  • 法规情形
  • 地区亲市场预测
  • 生产·消费统计
  • 进口和出口的统计

第4章 病患自控镇痛帮浦的全球市场分析

  • 过去的市场规模金额(一百万美元)数量(单位)分析，2019年～2023年
  • 现在及未来市场规模，金额(一百万美元)和数量(单位)的预测，2024年～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对额的机会分析

第5章 病患自控镇痛帮浦的全球市场分析:各类型

  • 简介/主要调查结果
  • 过去的市场规模金额(一百万美元)和数量(单位)的分析:各类型，2019年～2023年
  • 现在及未来市场规模金额(一百万美元)和数量(单位)的分析与预测:各类型，2024年～2033年
    • 电子
    • 机器
  • 与前一年同期比较成长趋势分析:各类型，2019年～2023年
  • 绝对额的机会分析:各类型，2024年～2033年

第6章 病患自控镇痛帮浦的全球市场分析:各用途

  • 简介/主要调查结果
  • 过去的市场规模金额(一百万美元)和数量(单位)的分析:各用途，2019年～2023年
  • 现在及未来市场规模金额(一百万美元)和数量(单位)的分析与预测:各用途，2024年～2033年
    • 糖尿病
    • 肿瘤学
    • 消化器官内科
    • 血液学
    • 其他的用途
  • 与前一年同期比较成长趋势分析:各用途，2019年～2023年
  • 绝对额的机会分析:各用途，2024年～2033年

第7章 病患自控镇痛帮浦的全球市场分析:各最终用途

  • 简介/主要调查结果
  • 过去的市场规模金额(一百万美元)和数量(单位)的分析:各最终用途，2019年～2023年
  • 现在及未来市场规模金额(一百万美元)和数量(单位)的分析与预测:各最终用途，2024年～2033年
    • 医院
    • 专门诊所
    • 门诊病人手术中心
    • 居家照护设定
  • 与前一年同期比较成长趋势分析:各最终用途，2019年～2023年
  • 绝对额的机会分析:各最终用途，2024年～2033年

第8章 病患自控镇痛帮浦的全球市场分析:各地区

  • 简介
  • 过去的市场规模(一百万美元)和数量(单位)的分析:各地区，2019年～2023年
  • 目前市场规模金额(一百万美元)和数量(单位)的分析与预测:各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 亚太地区
    • 中东·非洲
  • 市场魅力分析:各地区

第9章 北美的病患自控镇痛帮浦市场分析:各国

第10章 南美的病患自控镇痛帮浦市场分析:各国

第11章 欧洲的病患自控镇痛帮浦市场分析:各国

第12章 亚太地区的病患自控镇痛帮浦市场分析:各国

第13章 中东·非洲病患自控镇痛帮浦市场分析:各国

第14章 主要国家的病患自控镇痛帮浦市场分析

  • 金额(一百万美元)和数量(单位)
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列

第15章 市场结构分析

  • 竞争仪表板
  • 竞争基准
  • 主要企业的市场占有率分析

第16章 竞争分析

  • 竞争的详细资讯
    • Smiths Group plc
    • Fresenius SE &Co KGaA
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • ICU Medical, Inc.
    • ACE Medical
    • Terumo Corporation
    • Pfizer Inc

第17章 所使用的前提条件与缩写

第18章 调查手法

简介目录
Product Code: PMRREP33269

Persistence Market Research has recently released a comprehensive report on the Patient-controlled Analgesic Pumps Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Patient-controlled Analgesic Pumps Market Size (2024E): USD 385.4 million
  • Projected Market Value (2033F): USD 712 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.1%

Patient-controlled Analgesic Pumps Market - Report Scope:

Patient-controlled analgesic pumps play a crucial role in managing pain effectively by allowing patients to self-administer medications within safe dosage limits. These pumps are utilized in hospitals, outpatient settings, and homecare environments, catering to diverse patient needs across various medical conditions, including post-operative pain management, chronic pain, and palliative care.

Market Growth Drivers:

The global patient-controlled analgesic pumps market is propelled by several key factors, including the growing prevalence of chronic pain conditions, increasing surgical procedures, and the rising preference for personalized pain management solutions. Technological advancements, such as the development of smart pumps with enhanced safety features and usability, are also contributing to market growth. Moreover, the shift towards outpatient and home-based care settings, driven by healthcare cost containment efforts and patient convenience, further stimulates market expansion.

Market Restraints:

Despite promising growth prospects, the patient-controlled analgesic pumps market faces challenges related to stringent regulatory requirements, concerns over medication errors, and the high cost of advanced pump technologies. Limited reimbursement coverage for these devices in some regions also poses barriers to market penetration, particularly in emerging economies.

Market Opportunities:

The patient-controlled analgesic pumps market presents significant growth opportunities driven by advancements in drug delivery technologies, increasing healthcare expenditure, and the expanding elderly population globally. The integration of digital health solutions, such as remote monitoring and data analytics, enhances patient outcomes and operational efficiencies, fostering market growth. Strategic collaborations, partnerships, and investments in research and development are crucial for capitalizing on emerging opportunities and maintaining competitive advantage in the evolving market landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the patient-controlled analgesic pumps market globally?
  • Which pump types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the patient-controlled analgesic pumps market?
  • Who are the key players contributing to the market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global patient-controlled analgesic pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global patient-controlled analgesic pumps market, including Smiths Group plc.,Fresenius Kabi Group,

Hospira, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced pump technologies, enhance user interface design, and improve patient safety features. Collaboration with healthcare providers, regulatory agencies, and patient advocacy groups facilitates market access and supports regulatory compliance. Moreover, emphasis on patient education, training programs, and clinical support services enhances market penetration and promotes safe and effective pain management practices.

Key Companies Profiled:

  • Smiths Group plc.
  • Fresenius Kabi Group
  • Hospira
  • Micrel Medical Devices,
  • Ace Medical Co. Ltd.
  • Terumo Corporation
  • B.Braun Melsungen AG
  • Baxter International
  • Becton Dickinson and Company
  • ICU Medical

Market Segments Covered in Patient-controlled Analgesic Pumps Market Analysis

By End Use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

By Type

  • Electronic
  • Mechanical

By Application

  • Diabetes
  • Oncology
  • Gastroenterology
  • Hematology
  • Other Applications

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Supply Chain Analysis
    • 3.5.1. Supply Side Participants and their Roles
      • 3.5.1.1. Producers
      • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
      • 3.5.1.3. Wholesalers and Distributors
    • 3.5.2. Value Added and Value Created at Node in the Supply Chain
    • 3.5.3. List of Raw Material Suppliers
    • 3.5.4. List of Existing and Potential Buyer's
  • 3.6. Investment Feasibility Matrix
  • 3.7. Value Chain Analysis
    • 3.7.1. Profit Margin Analysis
    • 3.7.2. Wholesalers and Distributors
    • 3.7.3. Retailers
  • 3.8. PESTLE and Porter's Analysis
  • 3.9. Regulatory Landscape
    • 3.9.1. By Key Regions
    • 3.9.2. By Key Countries
  • 3.10. Regional Parent Market Outlook
  • 3.11. Production and Consumption Statistics
  • 3.12. Import and Export Statistics

4. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2024-2033
    • 5.3.1. Electronic
    • 5.3.2. Mechanical
  • 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type, 2024-2033

6. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2024-2033
    • 6.3.1. Diabetes
    • 6.3.2. Oncology
    • 6.3.3. Gastroenterology
    • 6.3.4. Hematology
    • 6.3.5. Other Applications
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2033

7. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End-use, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End-use, 2024-2033
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Home Care Settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

8. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2033
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 9.2.1. By Country
      • 9.2.1.1. Value (US$ Mn) & Volume (Units)ed States
      • 9.2.1.2. Canada
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-use
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Application
    • 9.3.4. By End-use
  • 9.4. Key Takeaways

10. Latin America Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End-use
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Application
    • 10.3.4. By End-use
  • 10.4. Key Takeaways

11. Europe Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. U.K.
      • 11.2.1.3. France
      • 11.2.1.4. Spain
      • 11.2.1.5. Italy
      • 11.2.1.6. Russia
      • 11.2.1.7. Rest of Europe
    • 11.2.2. By Type
    • 11.2.3. By Application
    • 11.2.4. By End-use
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Application
    • 11.3.4. By End-use
  • 11.4. Key Takeaways

12. Asia Pacific Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. India
      • 12.2.1.4. South Korea
      • 12.2.1.5. Australia
      • 12.2.1.6. Rest of APAC
    • 12.2.2. By Type
    • 12.2.3. By Application
    • 12.2.4. By End-use
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Application
    • 12.3.4. By End-use
  • 12.4. Key Takeaways

13. MEA Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 13.2.1. By Country
      • 13.2.1.1. South Africa
      • 13.2.1.2. Saudi Arabia
      • 13.2.1.3. UAE
      • 13.2.1.4. Israel
      • 13.2.1.5. Rest of MEA
    • 13.2.2. By Type
    • 13.2.3. By Application
    • 13.2.4. By End-use
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Type
    • 13.3.3. By Application
    • 13.3.4. By End-use
  • 13.4. Key Takeaways

14. Key Countries Patient-controlled Analgesic Pumps Market Analysis

  • 14.1. Value (US$ Mn) & Volume (Units)ed States
    • 14.1.1. Pricing Analysis
    • 14.1.2. Market Share Analysis, 2024
      • 14.1.2.1. By Type
      • 14.1.2.2. By Application
      • 14.1.2.3. By End-use
  • 14.2. Canada
    • 14.2.1. Pricing Analysis
    • 14.2.2. Market Share Analysis, 2024
      • 14.2.2.1. By Type
      • 14.2.2.2. By Application
      • 14.2.2.3. By End-use
  • 14.3. Brazil
    • 14.3.1. Pricing Analysis
    • 14.3.2. Market Share Analysis, 2024
      • 14.3.2.1. By Type
      • 14.3.2.2. By Application
      • 14.3.2.3. By End-use
  • 14.4. Mexico
    • 14.4.1. Pricing Analysis
    • 14.4.2. Market Share Analysis, 2024
      • 14.4.2.1. By Type
      • 14.4.2.2. By Application
      • 14.4.2.3. By End-use
  • 14.5. Germany
    • 14.5.1. Pricing Analysis
    • 14.5.2. Market Share Analysis, 2024
      • 14.5.2.1. By Type
      • 14.5.2.2. By Application
      • 14.5.2.3. By End-use
  • 14.6. U.K.
    • 14.6.1. Pricing Analysis
    • 14.6.2. Market Share Analysis, 2024
      • 14.6.2.1. By Type
      • 14.6.2.2. By Application
      • 14.6.2.3. By End-use
  • 14.7. France
    • 14.7.1. Pricing Analysis
    • 14.7.2. Market Share Analysis, 2024
      • 14.7.2.1. By Type
      • 14.7.2.2. By Application
      • 14.7.2.3. By End-use
  • 14.8. Spain
    • 14.8.1. Pricing Analysis
    • 14.8.2. Market Share Analysis, 2024
      • 14.8.2.1. By Type
      • 14.8.2.2. By Application
      • 14.8.2.3. By End-use
  • 14.9. Italy
    • 14.9.1. Pricing Analysis
    • 14.9.2. Market Share Analysis, 2024
      • 14.9.2.1. By Type
      • 14.9.2.2. By Application
      • 14.9.2.3. By End-use
  • 14.10. Russia
    • 14.10.1. Pricing Analysis
    • 14.10.2. Market Share Analysis, 2024
      • 14.10.2.1. By Type
      • 14.10.2.2. By Application
      • 14.10.2.3. By End-use
  • 14.11. China
    • 14.11.1. Pricing Analysis
    • 14.11.2. Market Share Analysis, 2024
      • 14.11.2.1. By Type
      • 14.11.2.2. By Application
      • 14.11.2.3. By End-use
  • 14.12. Japan
    • 14.12.1. Pricing Analysis
    • 14.12.2. Market Share Analysis, 2024
      • 14.12.2.1. By Type
      • 14.12.2.2. By Application
      • 14.12.2.3. By End-use
  • 14.13. India
    • 14.13.1. Pricing Analysis
    • 14.13.2. Market Share Analysis, 2024
      • 14.13.2.1. By Type
      • 14.13.2.2. By Application
      • 14.13.2.3. By End-use
  • 14.14. South Korea
    • 14.14.1. Pricing Analysis
    • 14.14.2. Market Share Analysis, 2024
      • 14.14.2.1. By Type
      • 14.14.2.2. By Application
      • 14.14.2.3. By End-use
  • 14.15. Australia
    • 14.15.1. Pricing Analysis
    • 14.15.2. Market Share Analysis, 2024
      • 14.15.2.1. By Type
      • 14.15.2.2. By Application
      • 14.15.2.3. By End-use
  • 14.16. South Africa
    • 14.16.1. Pricing Analysis
    • 14.16.2. Market Share Analysis, 2024
      • 14.16.2.1. By Type
      • 14.16.2.2. By Application
      • 14.16.2.3. By End-use
  • 14.17. Saudi Arabia
    • 14.17.1. Pricing Analysis
    • 14.17.2. Market Share Analysis, 2024
      • 14.17.2.1. By Type
      • 14.17.2.2. By Application
      • 14.17.2.3. By End-use
  • 14.18. UAE
    • 14.18.1. Pricing Analysis
    • 14.18.2. Market Share Analysis, 2024
      • 14.18.2.1. By Type
      • 14.18.2.2. By Application
      • 14.18.2.3. By End-use
  • 14.19. Israel
    • 14.19.1. Pricing Analysis
    • 14.19.2. Market Share Analysis, 2024
      • 14.19.2.1. By Type
      • 14.19.2.2. By Application
      • 14.19.2.3. By End-use

15. Market Structure Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Market Share Analysis of Top Players
    • 15.3.1. By Regional
    • 15.3.2. By Type
    • 15.3.3. By Application
    • 15.3.4. By End-use

16. Competition Analysis

  • 16.1. Competition Deep Dive
    • 16.1.1. Smiths Group plc
      • 16.1.1.1. Overview
      • 16.1.1.2. Product Portfolio
      • 16.1.1.3. Profitability by Market Segments
      • 16.1.1.4. Sales Footprint
      • 16.1.1.5. Strategy Overview
        • 16.1.1.5.1. Marketing Strategy
        • 16.1.1.5.2. Product Strategy
        • 16.1.1.5.3. Channel Strategy
    • 16.1.2. Fresenius SE & Co KGaA
      • 16.1.2.1. Overview
      • 16.1.2.2. Product Portfolio
      • 16.1.2.3. Profitability by Market Segments
      • 16.1.2.4. Sales Footprint
      • 16.1.2.5. Strategy Overview
        • 16.1.2.5.1. Marketing Strategy
        • 16.1.2.5.2. Product Strategy
        • 16.1.2.5.3. Channel Strategy
    • 16.1.3. B. Braun Melsungen AG
      • 16.1.3.1. Overview
      • 16.1.3.2. Product Portfolio
      • 16.1.3.3. Profitability by Market Segments
      • 16.1.3.4. Sales Footprint
      • 16.1.3.5. Strategy Overview
        • 16.1.3.5.1. Marketing Strategy
        • 16.1.3.5.2. Product Strategy
        • 16.1.3.5.3. Channel Strategy
    • 16.1.4. Baxter International Inc.
      • 16.1.4.1. Overview
      • 16.1.4.2. Product Portfolio
      • 16.1.4.3. Profitability by Market Segments
      • 16.1.4.4. Sales Footprint
      • 16.1.4.5. Strategy Overview
        • 16.1.4.5.1. Marketing Strategy
        • 16.1.4.5.2. Product Strategy
        • 16.1.4.5.3. Channel Strategy
    • 16.1.5. Becton, Dickinson and Company
      • 16.1.5.1. Overview
      • 16.1.5.2. Product Portfolio
      • 16.1.5.3. Profitability by Market Segments
      • 16.1.5.4. Sales Footprint
      • 16.1.5.5. Strategy Overview
        • 16.1.5.5.1. Marketing Strategy
        • 16.1.5.5.2. Product Strategy
        • 16.1.5.5.3. Channel Strategy
    • 16.1.6. ICU Medical, Inc.
      • 16.1.6.1. Overview
      • 16.1.6.2. Product Portfolio
      • 16.1.6.3. Profitability by Market Segments
      • 16.1.6.4. Sales Footprint
      • 16.1.6.5. Strategy Overview
        • 16.1.6.5.1. Marketing Strategy
        • 16.1.6.5.2. Product Strategy
        • 16.1.6.5.3. Channel Strategy
    • 16.1.7. ACE Medical
      • 16.1.7.1. Overview
      • 16.1.7.2. Product Portfolio
      • 16.1.7.3. Profitability by Market Segments
      • 16.1.7.4. Sales Footprint
      • 16.1.7.5. Strategy Overview
        • 16.1.7.5.1. Marketing Strategy
        • 16.1.7.5.2. Product Strategy
        • 16.1.7.5.3. Channel Strategy
    • 16.1.8. Terumo Corporation
      • 16.1.8.1. Overview
      • 16.1.8.2. Product Portfolio
      • 16.1.8.3. Profitability by Market Segments
      • 16.1.8.4. Sales Footprint
      • 16.1.8.5. Strategy Overview
        • 16.1.8.5.1. Marketing Strategy
        • 16.1.8.5.2. Product Strategy
        • 16.1.8.5.3. Channel Strategy
    • 16.1.9. Pfizer Inc
      • 16.1.9.1. Overview
      • 16.1.9.2. Product Portfolio
      • 16.1.9.3. Profitability by Market Segments
      • 16.1.9.4. Sales Footprint
      • 16.1.9.5. Strategy Overview
        • 16.1.9.5.1. Marketing Strategy
        • 16.1.9.5.2. Product Strategy
        • 16.1.9.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology